首页/数据集/Senescence rewires microenvironment sensing to facilitate anti-tumor immunity. Senescence rewires microenvironment sensing to facilitate anti-tumor immunity

Senescence rewires microenvironment sensing to facilitate anti-tumor immunity. Senescence rewires microenvironment sensing to facilitate anti-tumor immunity

NIAID Data Ecosystem2026-03-14 收录

细胞衰老

肿瘤免疫微环境

数据链接：

https://www.ncbi.nlm.nih.gov/bioproject/PRJNA928706 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

应用场景：

创建时间：

2023-01-27

肿瘤免疫微环境

COVID-19并发症

Coronavirus disease 2019 (COVID-19), which is known to be caused by the virus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by pneumonia, cytokine storms, and lymphope

NIAID Data Ecosystem40

DataSheet_1_MMP11 is associated with the immune response and immune microenvironment in EGFR-mutant lung adenocarcinoma.xlsx

肿瘤免疫微环境

肺癌生物标志物

BackgroundHigh expression of matrix metalloproteinase-11 (MMP11) is associated with various tumors and immune microenvironments. Conversely, poor response to immunotherapy in epidermal growth factor r

NIAID Data Ecosystem20

Impact of CD4 T cells on intratumoral CD8 T cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors

肿瘤免疫微环境

免疫检查点阻断治疗

scRNA-seq data (Cellranger filtered feature-barcode matrices) and scVDJ-seq data (Cellranger filtered_contig_annotations.csv files) for publication listed above.

Zenodo2022-05-11 更新00

Table_3_Novel CircRNAs in Hub ceRNA Axis Regulate Gastric Cancer Prognosis and Microenvironment.XLS

肿瘤免疫微环境

环状RNA调控网络

Gastric cancer (GC) is one of the most prevalent malignancies with an unfavorable survival rate. Immunotherapy may contribute to a better prognosis. However, several phase III trials failed. Circular

NIAID Data Ecosystem20

DataSheet1_High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration.ZIP

癌症生物标志物

肿瘤免疫微环境

Prostate adenocarcinoma (PRAD) is a common malignancy with increasing morbidity and mortality. Kinetochore scaffold 1 (KNL1) has been reported to be involved in tumor progression and prognosis in othe

NIAID Data Ecosystem10